Chesapeake Asset Management’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-3,970
Closed -$912K – 63
2015
Q4
$912K Sell
3,970
-30
-0.8% -$7.71K 0.7% 42
2015
Q3
$1.23M Hold
4,000
– – 1.05% 34
2015
Q2
$919K Buy
+4,000
New +$992K 0.67% 39

Other funds holding BIS

Chesapeake Asset Management's BIS Position: Q1 2016 in Review

Chesapeake Asset Management sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q1 2016, closing a stake of 3,970 shares — an estimated $912K sold.

Chesapeake Asset Management first reported a position in BIS in Q2 2015 and held it in 3 quarters. The position peaked at $1.23M in Q3 2015. 14 funds tracked by Wall St. Rank hold BIS as of Q1 2016.

  • Chesapeake Asset Management reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q1 2016 after selling out during the quarter.
  • Chesapeake Asset Management sold 3,970 ProShares UltraShort NASDAQ Biotechnology shares in Q1 2016, an estimated $912K.
  • Chesapeake Asset Management first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2015 and held it in 3 quarters.
  • Chesapeake Asset Management's ProShares UltraShort NASDAQ Biotechnology position peaked at $1.23M in Q3 2015.
  • 14 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q1 2016.

Based on Chesapeake Asset Management's 13F filing for Q1 2016, filed 10 May 2016.